Publication | Open Access
DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CLpro) of SARS-CoV-2
46
Citations
63
References
2021
Year
Md Simulation InvestigationAntiviral Drug DevelopmentAntiviral TherapyViral ProteaseVirologyAntiviral DrugViral Structural ProteinMedicineAntiviral CompoundAntiviral OptionCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1